The passing Of Dave Mangelsdorf is a terrible loss for his family, friends and the science world. Davo will never be forgotten. 😢 https://t.co/JQzVDG9RWS
The authors propose that combined targeting of liver and gut ALDH2, and manipulation of bile flow and secretion are potential therapeutic strategies to treat alcohol use disorder https://t.co/MuYAqQ5l6a @NatMetabolism
1/ This is the next chapter of a story about courageous patients and their families, of multidisciplinary teamwork, and hard-fought steps forward to effective therapy for #DIPG#DMG, a universally lethal cancer of the brain and spinal cord. 🧵https://t.co/hMe0XYplKz
Planning on attending the Alcohol #GRC in 2026? There are potential options -let us know what you prefer! Pomona is Feb 15-20 and other locations are Feb 21-27.
Very excited to announce that I'll be opening the Laboratory of Virus-Host Dialogue (https://t.co/Px7yebIMbp) as an Assistant Professor at @CUAnschutz this fall!
Our @NIDDKgov lab is seeking a #postdoc for exciting project assessing how human #liver in #MASLD handles fasted-to-fed transition.
Unicorns comfortable with bioinformatics, molecular biology and physiology should apply.
Details 👇
Friends please RT!
https://t.co/ugwUtsOkBK
@jclinicalinvest@YJEric_Fu@gaobinge@NIAAAnews And if you missed it, former postbac in the lab Taylor Lehner wrote a great review on alcohol metabolism in alcohol use disorder which I highly recommend!
https://t.co/u1csieg7Dz (open access)
Our review, "Alcohol-associated liver disease" has been published in @jclinicalinvest !
https://t.co/dlCWeHHB7s (open access)
It was great to collaborate with @YJEric_Fu on this, thanks to Luca, @gaobinge , and @NIAAAnews for the support!
@ebtapper Thanks for the shoutout @ebtapper !
It was great to collaborate with @YJEric_Fu on this, big thanks to @gaobinge , Luca, and @NIAAAnews .
Also, thanks to @jclinicalinvest for the seamless process and Amanda Humphrey for the figure preparation!
📖 'Alcohol-associated bowel disease: new insights into pathogenesis'
https://t.co/MUvjQy4j1y
This article nicely reviews its clinical features and pathogenesis.
@gaobinge@bmj_company@Gut_BMJ
Latest #GUTAbstract by @YJEric_Fu@NIAAAnews@NIH on
"MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression" via https://t.co/0r5FvX4VUm
Paper via https://t.co/0JZuLHNETV
#LiverTwitter